PARK7 and cancer: It is cytoprotective at lower concentrations by inducing NRF2 but at higher concentrations it inhibits the NRF2 stabilizer DJ-1, which in turn inhibits NRF2 activation, induces ROS, and subsequently promotes cancer cell death.